**Core Concept**
Bronchial asthma is a chronic inflammatory disorder of the airways characterized by episodic airflow obstruction, reversible airflow limitation, and airway hyperresponsiveness. This condition is mediated by an imbalance in the immune response, leading to the release of various inflammatory mediators and the activation of airway smooth muscle cells.

**Why the Correct Answer is Right**
The pathophysiology of bronchial asthma involves the release of inflammatory mediators such as histamine, leukotrienes, and cytokines from mast cells, eosinophils, and T lymphocytes. These mediators stimulate the contraction of airway smooth muscle cells, leading to bronchoconstriction and airflow limitation. The airway hyperresponsiveness seen in asthma is due to the increased expression of adhesion molecules and the activation of airway epithelial cells, which contributes to the recruitment of inflammatory cells to the airway wall.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately describe the pathophysiology of bronchial asthma. While inflammation is indeed a key component of asthma, the statement is too vague and does not capture the complexity of the condition.
**Option B:** This option is incorrect as it is too narrow and only focuses on one aspect of asthma pathophysiology. Bronchial asthma is a multifactorial disorder that involves the interplay of various inflammatory cells, mediators, and airway smooth muscle cells.
**Option C:** This option is incorrect as it is too broad and does not specifically describe the pathophysiology of bronchial asthma. Airway obstruction and inflammation are common to many respiratory conditions, not just asthma.

**Clinical Pearl / High-Yield Fact**
A key clinical feature of bronchial asthma is its reversibility with bronchodilators, which can be used to diagnose the condition. This reversibility is due to the fact that the airway obstruction seen in asthma is not fixed and can be alleviated with bronchodilator therapy.

**Correct Answer: A. Chronic inflammatory disorder of the airways characterized by episodic airflow obstruction, reversible airflow limitation, and airway hyperresponsiveness.**